Protalix BioTherapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2022 | 62.5% | -11.6% | -14.2% |
| Jun 2022 | 53.3% | -63.1% | -60.9% |
| Sep 2022 | 50.1% | -22.0% | -25.1% |
| Dec 2022 | 72.2% | -29.0% | -43.4% |
| Mar 2023 | 67.8% | -25.6% | -32.7% |
| Jun 2023 | 82.5% | 58.2% | 55.1% |
| Sep 2023 | 52.7% | -18.2% | -17.9% |
| Dec 2023 | 15.5% | -53.5% | -57.6% |
| Mar 2024 | 30.6% | -129.6% | -122.6% |
| Jun 2024 | 29.8% | -18.0% | -16.4% |
| Sep 2024 | 53.4% | 22.2% | 18.0% |
| Dec 2024 | 78.7% | 39.6% | 35.6% |
| Mar 2025 | 19.1% | -41.0% | -35.8% |
| Jun 2025 | 62.5% | 7.5% | 1.0% |
| Sep 2025 | 53.4% | 11.9% | 13.2% |
| Dec 2025 | 49.4% | -51.1% | -60.3% |
| Mar 2026 | 87.8% | 62.7% | 54.3% |
| Jun 2026 | 61.0% | 23.5% | 19.0% |